Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
![]() |
McKessonMCK |
-$82,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros | Jun 16, 2025 | Sell | $1K - $15K |
| Lisa McClain | Jun 11, 2025 | Buy | $1K - $15K |
| Rob Bresnahan | Jan 13, 2025 | Sell | $1K - $15K |
| Josh Gottheimer | Nov 7, 2024 | Sell | $1K - $15K |
| Josh Gottheimer | Jun 21, 2024 | Sell | $1K - $15K |
FAQ - Congress Trading
Gilbert Cisneros sold Healthequity shares most recently on June 16, 2025.
Lisa McClain has bought the most HQY stock in the last 2 years, with an estimated value of $8,000.
Josh Gottheimer has sold the most HQY stock in the last 2 years, with an estimated value of $16,000.
The net value of trades by US politicians for Healthequity in the last 2 years is negative, amounting to -$24,000. This suggests that US politicians do not believe in the success of the company for various reasons.
Over the last 2 years, insider transactions for Healthequity have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
